PubMed:1847912
Annnotations
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 0-8 | Cell | denotes | Platelet | http://purl.obolibrary.org/obo/CL:0000233 |
| T2 | 231-239 | Cell | denotes | platelet | http://purl.obolibrary.org/obo/CL:0000233 |
| T3 | 690-718 | Cell | denotes | vascular smooth muscle cells | http://purl.obolibrary.org/obo/CL:0000359 |
| T4 | 699-718 | Cell | denotes | smooth muscle cells | http://purl.obolibrary.org/obo/CL:0000192 |
| T5 | 1890-1905 | Cell | denotes | receptor, cells | http://purl.obolibrary.org/obo/CL:0000197 |
GlyCosmos15-Species
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 60 | 686-689 | Species | denotes | rat | 10116 |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 138-145 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T3 | 508-515 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T5 | 1868-1875 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T7 | 1930-1937 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T9 | 1975-1982 | Glycan_Motif | denotes | Heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T11 | 1992-2003 | Glycan_Motif | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT |
| T12 | 2272-2279 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-195 | Sentence | denotes | Platelet-derived growth factor-mediated Ca2+ entry is blocked by antibodies to phosphatidylinositol 4,5-bisphosphate but does not involve heparin-sensitive inositol 1,4,5-trisphosphate receptors. |
| T2 | 196-400 | Sentence | denotes | Elevation of intracellular Ca2+ by platelet-derived growth factor (PDGF) and other growth factors involves both release of Ca2+ from intracellular Ca2+ stores and Ca2+ entry from the extracellular medium. |
| T3 | 401-539 | Sentence | denotes | Release from intracellular stores is believed to be mediated by inositol 1,4,5-trisphosphate (IP3) and the heparin-sensitive IP3 receptor. |
| T4 | 540-621 | Sentence | denotes | We studied the mechanism by which entry of extracellular Ca2+ is induced by PDGF. |
| T5 | 622-756 | Sentence | denotes | Intracellular free Ca2+ (Ca2+i) was measured in single cultured rat vascular smooth muscle cells using fura 2 microspectrofluorometry. |
| T6 | 757-993 | Sentence | denotes | In nominally Ca2(+)-free medium, PDGF (recombinant BB, 10 ng/ml) raised intracellular Ca2+ transiently (less than 5 min); addition of 2 mM Ca2+ to the bathing medium after 5 min caused a second, prolonged increase in intracellular Ca2+. |
| T7 | 994-1124 | Sentence | denotes | Repeated changes in extracellular Ca2+ from 0 to 2 mM over 90 min caused rapid, parallel changes in Ca2+i of approximately 200 nM. |
| T8 | 1125-1255 | Sentence | denotes | This change in Ca2+i in response to changes in extracellular Ca2+ was virtually undetectable in control or thrombin-treated cells. |
| T9 | 1256-1391 | Sentence | denotes | The intracellular response to changes in medium Ca2+ after PDGF was completely blocked by 10 mM CoCl2, but not by 10(-7) M nicardipine. |
| T10 | 1392-1594 | Sentence | denotes | Microinjection of monoclonal antibodies to phosphatidylinositol 4,5-bisphosphate (PIP2) (kt 10, 2 mg/ml) totally abolished both mobilization of intracellular Ca2+ stores and entry of extracellular Ca2+. |
| T11 | 1595-1808 | Sentence | denotes | Consistent with this finding, maintenance of Ca2+ entry required ongoing receptor occupancy, since displacement of PDGF from its receptor with suramin (1 mM) eradicated extracellular Ca2+ entry in less than 5 min. |
| T12 | 1809-1974 | Sentence | denotes | To determine whether extracellular Ca2+ entry involves the heparin-sensitive IP3 receptor, cells were microinjected with heparin (4 mg/ml) prior to addition of PDGF. |
| T13 | 1975-2109 | Sentence | denotes | Heparin, but not chondroitin sulfate, prevented mobilization of intracellular Ca2+ stores but did not affect extracellular Ca2+ entry. |
| T14 | 2110-2191 | Sentence | denotes | We PDGF requires ongoing receptor occupancy and involves PIP2 or PIP2 metabolism. |
| T15 | 2192-2303 | Sentence | denotes | However, the signal which mediates PDGF-induced Ca2+ entry does not require the heparin-sensitive IP3 receptor. |
| T1 | 0-195 | Sentence | denotes | Platelet-derived growth factor-mediated Ca2+ entry is blocked by antibodies to phosphatidylinositol 4,5-bisphosphate but does not involve heparin-sensitive inositol 1,4,5-trisphosphate receptors. |
| T2 | 196-400 | Sentence | denotes | Elevation of intracellular Ca2+ by platelet-derived growth factor (PDGF) and other growth factors involves both release of Ca2+ from intracellular Ca2+ stores and Ca2+ entry from the extracellular medium. |
| T3 | 401-539 | Sentence | denotes | Release from intracellular stores is believed to be mediated by inositol 1,4,5-trisphosphate (IP3) and the heparin-sensitive IP3 receptor. |
| T4 | 540-621 | Sentence | denotes | We studied the mechanism by which entry of extracellular Ca2+ is induced by PDGF. |
| T5 | 622-756 | Sentence | denotes | Intracellular free Ca2+ (Ca2+i) was measured in single cultured rat vascular smooth muscle cells using fura 2 microspectrofluorometry. |
| T6 | 757-993 | Sentence | denotes | In nominally Ca2(+)-free medium, PDGF (recombinant BB, 10 ng/ml) raised intracellular Ca2+ transiently (less than 5 min); addition of 2 mM Ca2+ to the bathing medium after 5 min caused a second, prolonged increase in intracellular Ca2+. |
| T7 | 994-1124 | Sentence | denotes | Repeated changes in extracellular Ca2+ from 0 to 2 mM over 90 min caused rapid, parallel changes in Ca2+i of approximately 200 nM. |
| T8 | 1125-1255 | Sentence | denotes | This change in Ca2+i in response to changes in extracellular Ca2+ was virtually undetectable in control or thrombin-treated cells. |
| T9 | 1256-1391 | Sentence | denotes | The intracellular response to changes in medium Ca2+ after PDGF was completely blocked by 10 mM CoCl2, but not by 10(-7) M nicardipine. |
| T10 | 1392-1594 | Sentence | denotes | Microinjection of monoclonal antibodies to phosphatidylinositol 4,5-bisphosphate (PIP2) (kt 10, 2 mg/ml) totally abolished both mobilization of intracellular Ca2+ stores and entry of extracellular Ca2+. |
| T11 | 1595-1808 | Sentence | denotes | Consistent with this finding, maintenance of Ca2+ entry required ongoing receptor occupancy, since displacement of PDGF from its receptor with suramin (1 mM) eradicated extracellular Ca2+ entry in less than 5 min. |
| T12 | 1809-1974 | Sentence | denotes | To determine whether extracellular Ca2+ entry involves the heparin-sensitive IP3 receptor, cells were microinjected with heparin (4 mg/ml) prior to addition of PDGF. |
| T13 | 1975-2109 | Sentence | denotes | Heparin, but not chondroitin sulfate, prevented mobilization of intracellular Ca2+ stores but did not affect extracellular Ca2+ entry. |
| T14 | 2110-2191 | Sentence | denotes | We PDGF requires ongoing receptor occupancy and involves PIP2 or PIP2 metabolism. |
| T15 | 2192-2303 | Sentence | denotes | However, the signal which mediates PDGF-induced Ca2+ entry does not require the heparin-sensitive IP3 receptor. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 138-145 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 138-145 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T3 | 508-515 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T4 | 508-515 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T5 | 1868-1875 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T6 | 1868-1875 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T7 | 1930-1937 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T8 | 1930-1937 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T9 | 1975-1982 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | Heparin |
| T10 | 1975-1982 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | Heparin |
| T11 | 1992-2003 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | chondroitin |
| T12 | 2272-2279 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T13 | 2272-2279 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1992-2003 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | chondroitin |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 699-712 | http://purl.obolibrary.org/obo/MAT_0000303 | denotes | smooth muscle |
| T2 | 706-712 | http://purl.obolibrary.org/obo/MAT_0000025 | denotes | muscle |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 1992-2003 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 1992-2003 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
GlyCosmos15-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 686-689 | OrganismTaxon | denotes | rat | 10114|10116 |
GlyCosmos15-CL
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 0-8 | Cell | denotes | Platelet | http://purl.obolibrary.org/obo/CL:0000233 |
| T2 | 231-239 | Cell | denotes | platelet | http://purl.obolibrary.org/obo/CL:0000233 |
| T3 | 690-718 | Cell | denotes | vascular smooth muscle cells | http://purl.obolibrary.org/obo/CL:0000359 |
| T4 | 699-718 | Cell | denotes | smooth muscle cells | http://purl.obolibrary.org/obo/CL:0000192 |
| T5 | 1890-1905 | Cell | denotes | receptor, cells | http://purl.obolibrary.org/obo/CL:0000197 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 0-8 | Body_part | denotes | Platelet | http://purl.obolibrary.org/obo/CL_0000233 |
| T2 | 209-222 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T3 | 231-239 | Body_part | denotes | platelet | http://purl.obolibrary.org/obo/CL_0000233 |
| T4 | 329-342 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T5 | 379-392 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T6 | 414-427 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T7 | 583-596 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T8 | 622-635 | Body_part | denotes | Intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T9 | 690-718 | Body_part | denotes | vascular smooth muscle cells | http://purl.obolibrary.org/obo/CL_0000359 |
| T10 | 829-842 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T11 | 974-987 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T12 | 1014-1027 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T13 | 1172-1185 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T14 | 1260-1273 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T15 | 1536-1549 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T16 | 1575-1588 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T17 | 1764-1777 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T18 | 1830-1843 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T19 | 1890-1905 | Body_part | denotes | receptor, cells | http://purl.obolibrary.org/obo/CL_0000197 |
| T20 | 2039-2052 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T21 | 2084-2097 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-195 | Sentence | denotes | Platelet-derived growth factor-mediated Ca2+ entry is blocked by antibodies to phosphatidylinositol 4,5-bisphosphate but does not involve heparin-sensitive inositol 1,4,5-trisphosphate receptors. |
| T2 | 196-400 | Sentence | denotes | Elevation of intracellular Ca2+ by platelet-derived growth factor (PDGF) and other growth factors involves both release of Ca2+ from intracellular Ca2+ stores and Ca2+ entry from the extracellular medium. |
| T3 | 401-539 | Sentence | denotes | Release from intracellular stores is believed to be mediated by inositol 1,4,5-trisphosphate (IP3) and the heparin-sensitive IP3 receptor. |
| T4 | 540-621 | Sentence | denotes | We studied the mechanism by which entry of extracellular Ca2+ is induced by PDGF. |
| T5 | 622-756 | Sentence | denotes | Intracellular free Ca2+ (Ca2+i) was measured in single cultured rat vascular smooth muscle cells using fura 2 microspectrofluorometry. |
| T6 | 757-993 | Sentence | denotes | In nominally Ca2(+)-free medium, PDGF (recombinant BB, 10 ng/ml) raised intracellular Ca2+ transiently (less than 5 min); addition of 2 mM Ca2+ to the bathing medium after 5 min caused a second, prolonged increase in intracellular Ca2+. |
| T7 | 994-1124 | Sentence | denotes | Repeated changes in extracellular Ca2+ from 0 to 2 mM over 90 min caused rapid, parallel changes in Ca2+i of approximately 200 nM. |
| T8 | 1125-1255 | Sentence | denotes | This change in Ca2+i in response to changes in extracellular Ca2+ was virtually undetectable in control or thrombin-treated cells. |
| T9 | 1256-1391 | Sentence | denotes | The intracellular response to changes in medium Ca2+ after PDGF was completely blocked by 10 mM CoCl2, but not by 10(-7) M nicardipine. |
| T10 | 1392-1594 | Sentence | denotes | Microinjection of monoclonal antibodies to phosphatidylinositol 4,5-bisphosphate (PIP2) (kt 10, 2 mg/ml) totally abolished both mobilization of intracellular Ca2+ stores and entry of extracellular Ca2+. |
| T11 | 1595-1808 | Sentence | denotes | Consistent with this finding, maintenance of Ca2+ entry required ongoing receptor occupancy, since displacement of PDGF from its receptor with suramin (1 mM) eradicated extracellular Ca2+ entry in less than 5 min. |
| T12 | 1809-1974 | Sentence | denotes | To determine whether extracellular Ca2+ entry involves the heparin-sensitive IP3 receptor, cells were microinjected with heparin (4 mg/ml) prior to addition of PDGF. |
| T13 | 1975-2109 | Sentence | denotes | Heparin, but not chondroitin sulfate, prevented mobilization of intracellular Ca2+ stores but did not affect extracellular Ca2+ entry. |
| T14 | 2110-2191 | Sentence | denotes | We PDGF requires ongoing receptor occupancy and involves PIP2 or PIP2 metabolism. |
| T15 | 2192-2303 | Sentence | denotes | However, the signal which mediates PDGF-induced Ca2+ entry does not require the heparin-sensitive IP3 receptor. |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 1992-2003 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
GlyCosmos15-FMA
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 0-8 | Body_part | denotes | Platelet | FMA:62851 |
| T2 | 231-239 | Body_part | denotes | platelet | FMA:62851 |
| T3 | 690-718 | Body_part | denotes | vascular smooth muscle cells | FMA:284560 |
GlyCosmos15-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 699-712 | Body_part | denotes | smooth muscle | http://purl.obolibrary.org/obo/MAT_0000303 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 686-689 | OrganismTaxon | denotes | rat | 10114|10116 |
GlyCosmos-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 1992-2003 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 699-712 | Body_part | denotes | smooth muscle | http://purl.obolibrary.org/obo/MAT_0000303 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 0-8 | Body_part | denotes | Platelet | http://purl.obolibrary.org/obo/CL_0000233 |
| T2 | 209-222 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T3 | 231-239 | Body_part | denotes | platelet | http://purl.obolibrary.org/obo/CL_0000233 |
| T4 | 329-342 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T5 | 379-392 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T6 | 414-427 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T7 | 583-596 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T8 | 622-635 | Body_part | denotes | Intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T9 | 690-718 | Body_part | denotes | vascular smooth muscle cells | http://purl.obolibrary.org/obo/CL_0000359 |
| T10 | 829-842 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T11 | 974-987 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T12 | 1014-1027 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T13 | 1172-1185 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T14 | 1260-1273 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T15 | 1536-1549 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T16 | 1575-1588 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T17 | 1764-1777 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T18 | 1830-1843 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
| T19 | 1890-1905 | Body_part | denotes | receptor, cells | http://purl.obolibrary.org/obo/CL_0000197 |
| T20 | 2039-2052 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
| T21 | 2084-2097 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |